Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Injections × Classical hematology × Clear all

Phase

Phase 3 2 Phase 4 1 Phase 2 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1 Plasma cell 1 Other hematologic neoplasm 1 Other 1 Lymphoid 1 Gynecologic 1 Genitourinary 1 Classical hematology 1

Conditions

Neoplasms 1 Febrile Neutropenia 1

Interventions

Epoetin Alfa 7 ferric carboxymaltose 6 epoetin beta 6 Meropenem 4 Ceftazidime 4 Vancomycin 3 Darbepoetin alfa 3 iron isomaltoside 1000 2 ferrous sulfate 2 ferrous fumarate 2 apixaban 2 Radiotherapy 2 Levofloxacin 2 Filgrastim 2 Enoxaparin 2 Dalteparin 2 Ciprofloxacin 2 Cholecalciferol 2 Cefepime 2 sotorasib 1 posaconazole 1 ferrous succinate 1 ferric gluconate 1 eltrombopag 1 ceftolozane, tazobactam drug combination 1 Vitamin B 12 1 Vaccination 1 Tinzaparin 1 Thrombopoietin 1 Thiotepa 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04948463 2025-12-24

ELSA-FN

Murdoch Childrens Research Institute

Phase 4 Completed

Classical hematology

Neoplasms, Febrile Neutropenia

Data powered by HemOnc (CC BY 4.0) Colophon ⚡